A Phase I study of 2-amino-9-B-D-arabinosyl-6-methoxy-9H-purine (506U78) administered on a consecutive five day schedule in children and adults with refractory hematologic malignancies.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Kurtzberg, J; Ernst, TJ; Keating, MJ; Gandhi, V; Hodge, JP; Kisor, DF; Therriault, R; Stephens, C; Levin, J; Krenitsky, T; Elion, GB; Mitchell, BS

Published Date

  • November 15, 1999

Published In

Volume / Issue

  • 94 / 10

Start / End Page

  • 629A - 629A

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0006-4971

Language

  • English